Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology

Heart Fail Clin. 2022 Jul;18(3):455-478. doi: 10.1016/j.hfc.2022.02.007.

Abstract

Cardiovascular (CV) events are an increasingly common limitation of effective anticancer therapy. Over the last decade imaging has become essential to patients receiving contemporary cancer therapy. Herein we discuss the current state of CV imaging in cardio-oncology. We also provide a practical apparatus for the use of imaging in everyday cardiovascular care of oncology patients to improve outcomes for those at risk for cardiotoxicity, or with established cardiovascular disease. Finally, we consider future directions in the field given the wave of new anticancer therapies.

Keywords: Advanced imaging; Cardiac MRI; Cardio-oncology; Echocardiography; Immunotherapy toxicity.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cardiotoxicity / diagnostic imaging
  • Cardiotoxicity / etiology
  • Cardiovascular Diseases* / diagnostic imaging
  • Echocardiography
  • Humans
  • Magnetic Resonance Imaging
  • Medical Oncology
  • Neoplasms* / complications
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents